Akeso (AKESF) said its experimental lung cancer treatment ivonescimab improved overall survival compared with a widely used ...

It’s the moment of truth for Akeso’s ivonescimab, and to many, a high-stakes test for China’s booming biotech industry. | ...

An experimental drug developed by China-based Akeso helped patients with advanced squamous non-small cell lung cancer live 15% longer than BeOne Medicines' immunotherapy Tevimbra, and cut the risk ...

TeLuRide-005, a Phase 2 trial of EIK1001 in first-line patients with stage 4 NSCLC completed enrollment of both non-squamous and squamous cohorts ...

New dual-action drug a ‘promising step forward’ for patients with hard-to-treat lung cancer - Experts have described the ...

If you’re spending time outdoors, wear sunblock and know the signs of this common skin cancer. It’s crucial to spot it early — before it becomes dangerous. According to the Skin Cancer Foundation (SCF ...

Cutaneous squamous cell carcinoma is the second most frequent malignancy in human beings (trailing only basal cell carcinoma). Recent reports have suggested that, in fact, squamous cell carcinoma may ...

The biology of carcinomas with squamous differentiation is intriguing. When all organs and sites are considered together, one might conclude that squamous cell carcinomas in general have a better ...

Squamous cells are small, flat skin cells in the outer layer of skin. When these cells become cancerous, they typically develop into flat or raised, rounded skin tumors. Sometimes the skin around the ...